Table 2.
Neutralizing Monoclonal Antibody Information
| mAb ID | Heavy Chain | Light Chain | Heavy Chain Junction AA Sequence | Heavy Chain Mutation # | Light Chain Mutation # |
|---|---|---|---|---|---|
| 202 | IGHV 3-66 | IGLV 1-40 | CARGGEEPLPFDPW | 7 | 0 |
| 203 | IGHV 1-69 | IGLV 1-40 | CARDEAQTTVNTNWFDPW | 11 | 6 |
| 206 | IGHV 3-66 | IGKV 1-39 | CARGDGSYYRAFDYW | 6 | 3 |
| 207 | IGHV 3-23 | IGlV 1-21 | CAKDPGTVTTYEYFQHW | 3 | 6 |
| 210 | IGHV 3-53 | IGKV 1-39 | CARDASSYGIDW | 5 | 3 |
| 228 | IGHV 3-66 | IGKV 1-33 | CARGVKDNIW | 6 | 3 |
| 234 | IGHV 3-53 | IGKV 3-20 | CARAFGGDYMDVW | 5 | 4 |
| 239 | IGHV 3-23 | IGLV 1-40 | CAKAGGRDYYDRSGTLNVGAWNFQHW | 5 | 2 |
| 278 | IGHV 1-46 | IGKV 1-39 | CARANSGSYHYYDYW | 12 | 4 |
| 277 | IGHV 4-59 | IGKV 3-20 | CARSWLRPHNWLDPW | 12 | 18 |
| 284 | IGHV 1-69 | IGKV 1-39 | CAGREKRWFGELNWDDGMDVW | 14 | 6 |
| 297 | IGHV 3-9 | IGKV 1-39 | CAKGHDPFHYYYYGMDVW | 11 | 7 |
| 300 | IGHV 1-69 | IGKV 1-39 | CASVSHYYDGSGYPTGFDPW | 10 | 1 |
| 305 | IGHV 3-53 | IGKV 1-NL1 | CARGPGVIIDW | 3 | 3 |
| 309 | IGHV 3-53 | IGKV 1-12 | CARELSSYYDLW | 5 | 10 |
Heavy and light chain gene usage, somatic hypermutation rate, and VDJ junction sequence of neutralizing antibodies.